全球伴侶動物藥品市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計伴侶動物藥品市場將從 2025 年的 203.7 億美元成長到 2034 年的 360.6 億美元，2026 年至 2034 年的複合年成長率為 6.55%。

受寵物飼養量增加和人們對動物健康與福祉意識不斷提高的推動，伴侶動物藥品市場正經歷顯著成長。隨著越來越多的家庭將寵物視為家庭成員，對獸醫服務和產品的需求也隨之激增。寵物飼主越來越積極尋求預防性護理，從而擴大了疫苗、診斷和治療產品的市場。這一趨勢在寵物飼養率高的地區尤其明顯，顯示消費者願意為動物健康和福利進行投資。隨著市場的不斷發展，獸醫學和技術的創新有望提升伴侶動物醫療保健的品質。

此外，寵物日益人性化正在對伴侶動物藥品市場產生重大影響。隨著寵物越來越被視為家庭成員，飼主也開始尋求與人類同等的高品質醫療保健服務。這種轉變推動了對先進療法的需求，包括針對伴侶動物特定需求的專科手術、牙科護理和營養補充劑。此外，遠端醫療的日益普及也讓飼主更容易獲得專家建議和服務，進一步擴大了市場。隨著人們對寵物健康和福祉的關注度不斷提高，伴侶動物醫療保健市場預計將持續成長，以滿足飼主不斷變化的需求。

此外，研發領域的進步正在推動伴侶動物藥品市場的發展。新藥、生物製藥和診斷工具的出現，提高了診斷和治療各種寵物疾病的能力。隨著獸醫專業人員獲得更多有效的治療方案，伴侶動物的整體護理品質有望得到提升。此外，獸醫專業人員與寵物產品製造商之間日益緊密的合作正在推動市場創新，並促成新型有效解決方案的開發。隨著伴侶動物藥品市場的不斷發展，在對高品質獸醫護理需求不斷成長的推動下，預計將保持持續成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球伴侶動物藥品市場：依適應症分類

• 市場分析、洞察與預測
• 感染疾病
• 皮膚病（皮膚病）
• 疼痛
• 整形外科疾病
• 行為障礙
• 其他（牙科、心臟、懷孕、癌症）

第5章 全球伴侶動物藥品市場：依給藥途徑分類

• 市場分析、洞察與預測
• 口服
• 注射藥物
• 局部行政部門

第6章 全球伴侶動物藥品市場：依動物類型分類

• 市場分析、洞察與預測
• 狗
• 貓
• 馬
• 其他伴侶動物

第7章 全球伴侶動物藥品市場：依通路分類

• 市場分析、洞察與預測
• 動物醫院
• 動物診所
• 零售藥房

第8章 全球伴侶動物藥品市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Zoetis
  • Merck Animal Health
  • Boehringer Ingelheim Animal Health
  • Elanco Animal Health
  • Ceva SantAfA（C）Animale
  • Virbac
  • Dechra Pharmaceuticals
  • Vetoquinol
  • Neogen Corporation
  • Orion Group
  • Norbrook Holdings
  • Chanelle Pharma
  • HIPRA
  • Kyoritsu Seiyaku
  • BiogAfA（C）NAfA（C）Sis BagAfA3

The Companion Animal Medicine Market size is expected to reach USD 36.06 Billion in 2034 from USD 20.37 Billion (2025) growing at a CAGR of 6.55% during 2026-2034.

The companion animal medicine market is experiencing significant growth, driven by the increasing pet ownership and the rising awareness of animal health and wellness. As more households welcome pets into their lives, the demand for veterinary services and products is surging. Pet owners are becoming more proactive in seeking preventive care, leading to a growing market for vaccines, diagnostics, and therapeutic treatments. This trend is particularly pronounced in regions with high pet ownership rates, where consumers are willing to invest in the health and well-being of their animals. As the market continues to evolve, innovations in veterinary medicine and technology are expected to enhance the quality of care available for companion animals.

Moreover, the growing trend of pet humanization is significantly influencing the companion animal medicine market. As pets are increasingly viewed as family members, owners are seeking high-quality medical care that mirrors human healthcare standards. This shift is driving demand for advanced treatments, including specialized surgeries, dental care, and nutritional supplements tailored to the unique needs of companion animals. Additionally, the rise of telemedicine in veterinary care is making it easier for pet owners to access professional advice and services, further expanding the market. As the focus on pet health and wellness continues to grow, the companion animal medicine market is expected to thrive, catering to the evolving needs of pet owners.

Furthermore, advancements in research and development are enhancing the companion animal medicine market. The emergence of new pharmaceuticals, biologics, and diagnostic tools is improving the ability to diagnose and treat various conditions in pets. As veterinary professionals gain access to more effective treatment options, the overall quality of care for companion animals is expected to improve. Additionally, the increasing collaboration between veterinary professionals and pet product manufacturers is fostering innovation in the market, leading to the development of new and effective solutions. As the companion animal medicine market continues to evolve, it is likely to witness sustained growth, driven by the increasing demand for high-quality veterinary care.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Indication

• Infectious Diseases
• Dermatologic Diseases (Skin Diseases)
• Pain
• Orthopedic Diseases
• Behavioral Disorders
• Others (Dental, Cardio, Pregnancy, Cancer)

By Route of Administration

• Oral
• Injectable
• Topical

By Animal Type

• Dogs
• Cats
• Horses
• Other Companion Animals

By Distribution Channel

• Veterinary Hospitals
• Veterinary Clinics
• Retail Pharmacies

COMPANIES PROFILED

• Zoetis, Merck Animal Health, Boehringer Ingelheim Animal Health, Elanco Animal Health, Ceva Sant Animale, Virbac, Dechra Pharmaceuticals, Vetoquinol, Neogen Corporation, Orion Group, Norbrook Holdings, Chanelle Pharma, HIPRA, Kyoritsu Seiyaku, Biognsis Bag

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL COMPANION ANIMAL MEDICINE MARKET: BY INDICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Indication
• 4.2. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Dermatologic Diseases (Skin Diseases) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Pain Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Orthopedic Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Behavioral Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Others (Dental, Cardio, Pregnancy, Cancer) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL COMPANION ANIMAL MEDICINE MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Route Of Administration
• 5.2. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Injectable Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Topical Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL COMPANION ANIMAL MEDICINE MARKET: BY ANIMAL TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Animal Type
• 6.2. Dogs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Cats Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Horses Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Other Companion Animals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL COMPANION ANIMAL MEDICINE MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Distribution Channel
• 7.2. Veterinary Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Veterinary Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL COMPANION ANIMAL MEDICINE MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Indication
  • 8.2.2 By Route Of Administration
  • 8.2.3 By Animal Type
  • 8.2.4 By Distribution Channel
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Indication
  • 8.3.2 By Route Of Administration
  • 8.3.3 By Animal Type
  • 8.3.4 By Distribution Channel
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Indication
  • 8.4.2 By Route Of Administration
  • 8.4.3 By Animal Type
  • 8.4.4 By Distribution Channel
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Indication
  • 8.5.2 By Route Of Administration
  • 8.5.3 By Animal Type
  • 8.5.4 By Distribution Channel
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Indication
  • 8.6.2 By Route Of Administration
  • 8.6.3 By Animal Type
  • 8.6.4 By Distribution Channel
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL COMPANION ANIMAL MEDICINE INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Zoetis
  • 10.2.2 Merck Animal Health
  • 10.2.3 Boehringer Ingelheim Animal Health
  • 10.2.4 Elanco Animal Health
  • 10.2.5 Ceva SantAfA(C) Animale
  • 10.2.6 Virbac
  • 10.2.7 Dechra Pharmaceuticals
  • 10.2.8 Vetoquinol
  • 10.2.9 Neogen Corporation
  • 10.2.10 Orion Group
  • 10.2.11 Norbrook Holdings
  • 10.2.12 Chanelle Pharma
  • 10.2.13 HIPRA
  • 10.2.14 Kyoritsu Seiyaku
  • 10.2.15 BiogAfA(C)NAfA(C)Sis BagAfA3